


RA Patients Taking Either 15 mg or 30 mg Dose of Upadacitinib Experience Improvement

RA Patients May Safely Stop Methotrexate in Tofacitinib Combination Therapy

Upadacitinib Monotherapy Proves Promising; Plus FDA Approves Tocilizumab Autoinjector

• By Arthritis & Rheumatology
Visit the official website for the American College of Rheumatology.
The Foundation is the largest private funding source for rheumatology research and training in the U.S.
Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.